A detailed history of Fmr LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Fmr LLC holds 38,374 shares of IKNA stock, worth $67,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,374
Previous 19,767 94.13%
Holding current value
$67,538
Previous $32,000 106.25%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.6 - $1.85 $29,771 - $34,422
18,607 Added 94.13%
38,374 $66,000
Q2 2024

Aug 13, 2024

BUY
$1.24 - $1.82 $17,317 - $25,418
13,966 Added 240.75%
19,767 $32,000
Q1 2024

May 13, 2024

SELL
$1.27 - $2.0 $5.31 Million - $8.36 Million
-4,178,492 Reduced 99.86%
5,801 $8,000
Q4 2023

Feb 13, 2024

SELL
$1.33 - $4.4 $364,208 - $1.2 Million
-273,841 Reduced 6.14%
4,184,293 $8.24 Million
Q3 2023

Nov 13, 2023

SELL
$4.09 - $6.43 $2.51 Million - $3.94 Million
-612,688 Reduced 12.08%
4,458,134 $19.3 Million
Q2 2023

Aug 11, 2023

BUY
$3.5 - $7.31 $6.15 Million - $12.8 Million
1,757,437 Added 53.04%
5,070,822 $33.3 Million
Q1 2023

May 11, 2023

SELL
$2.62 - $4.97 $1.08 Million - $2.04 Million
-411,190 Reduced 11.04%
3,313,385 $11.4 Million
Q4 2022

Feb 13, 2023

BUY
$2.0 - $3.7 $2.4 Million - $4.43 Million
1,198,372 Added 47.44%
3,724,575 $9.91 Million
Q3 2022

Nov 10, 2022

SELL
$3.46 - $6.0 $6.47 Million - $11.2 Million
-1,869,516 Reduced 42.53%
2,526,203 $8.97 Million
Q2 2022

Aug 12, 2022

SELL
$3.23 - $7.4 $868,036 - $1.99 Million
-268,742 Reduced 5.76%
4,395,719 $19.5 Million
Q1 2022

May 13, 2022

SELL
$5.61 - $13.85 $332,257 - $820,280
-59,226 Reduced 1.25%
4,664,461 $28.5 Million
Q4 2021

Feb 14, 2022

SELL
$10.52 - $16.96 $3.23 Million - $5.21 Million
-307,453 Reduced 6.11%
4,723,687 $59.2 Million
Q3 2021

Nov 15, 2021

BUY
$9.82 - $15.23 $5.89 Million - $9.13 Million
599,483 Added 13.53%
5,031,140 $63.5 Million
Q2 2021

Aug 13, 2021

BUY
$13.27 - $26.0 $58.8 Million - $115 Million
4,431,657 New
4,431,657 $62.2 Million

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $63.8M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.